These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15180262)

  • 41. A transgenic mouse model for gene therapy of rhodopsin-linked Retinitis Pigmentosa.
    O'Reilly M; Millington-Ward S; Palfi A; Chadderton N; Cronin T; McNally N; Humphries MM; Humphries P; Kenna PF; Farrar GJ
    Vision Res; 2008 Feb; 48(3):386-91. PubMed ID: 17920651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of AAV-Mediated Rhodopsin Gene Augmentation on Retinal Degeneration Caused by the Dominant P23H Rhodopsin Mutation in a Knock-In Murine Model.
    Orlans HO; Barnard AR; Patrício MI; McClements ME; MacLaren RE
    Hum Gene Ther; 2020 Jul; 31(13-14):730-742. PubMed ID: 32394751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of Mouse Models of Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation of Rhodopsin.
    Barwick SR; Smith SB
    Adv Exp Med Biol; 2023; 1415():341-345. PubMed ID: 37440054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness.
    Rao VR; Cohen GB; Oprian DD
    Nature; 1994 Feb; 367(6464):639-42. PubMed ID: 8107847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unfolding retinal dystrophies: a role for molecular chaperones?
    Chapple JP; Grayson C; Hardcastle AJ; Saliba RS; van der Spuy J; Cheetham ME
    Trends Mol Med; 2001 Sep; 7(9):414-21. PubMed ID: 11530337
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular mechanisms of disease for mutations at Gly-90 in rhodopsin.
    Toledo D; Ramon E; Aguilà M; Cordomí A; Pérez JJ; Mendes HF; Cheetham ME; Garriga P
    J Biol Chem; 2011 Nov; 286(46):39993-40001. PubMed ID: 21940625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rhodopsin gene expression determines rod outer segment size and rod cell resistance to a dominant-negative neurodegeneration mutant.
    Price BA; Sandoval IM; Chan F; Nichols R; Roman-Sanchez R; Wensel TG; Wilson JH
    PLoS One; 2012; 7(11):e49889. PubMed ID: 23185477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa.
    Wu WH; Tsai YT; Huang IW; Cheng CH; Hsu CW; Cui X; Ryu J; Quinn PMJ; Caruso SM; Lin CS; Tsang SH
    Mol Ther; 2022 Apr; 30(4):1407-1420. PubMed ID: 35150888
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype.
    Han Z; Banworth MJ; Makkia R; Conley SM; Al-Ubaidi MR; Cooper MJ; Naash MI
    FASEB J; 2015 Jun; 29(6):2535-44. PubMed ID: 25713057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dark rearing rescues P23H rhodopsin-induced retinal degeneration in a transgenic Xenopus laevis model of retinitis pigmentosa: a chromophore-dependent mechanism characterized by production of N-terminally truncated mutant rhodopsin.
    Tam BM; Moritz OL
    J Neurosci; 2007 Aug; 27(34):9043-53. PubMed ID: 17715341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ocular findings in patients with autosomal dominant retinitis pigmentosa and rhodopsin, proline-347-leucine.
    Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Dryja TP
    Am J Ophthalmol; 1991 May; 111(5):614-23. PubMed ID: 2021172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of disease-linked rhodopsin mutations based on structure, function, and protein stability calculations.
    Rakoczy EP; Kiel C; McKeone R; Stricher F; Serrano L
    J Mol Biol; 2011 Jan; 405(2):584-606. PubMed ID: 21094163
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unusual thermal and conformational properties of the rhodopsin congenital night blindness mutant Thr-94 --> Ile.
    Ramon E; del Valle LJ; Garriga P
    J Biol Chem; 2003 Feb; 278(8):6427-32. PubMed ID: 12466267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the retinitis pigmentosa mutations in rhodopsin with a functional map of the C5a receptor.
    Hagemann IS; Nikiforovich GV; Baranski TJ
    Vision Res; 2006 Dec; 46(27):4519-31. PubMed ID: 16962629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting the Proteostasis Network in Rhodopsin Retinitis Pigmentosa.
    Parfitt DA; Cheetham ME
    Adv Exp Med Biol; 2016; 854():479-84. PubMed ID: 26427449
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autosomal dominant retinitis pigmentosa: a novel mutation in the rhodopsin gene in the original 3q linked family.
    Farrar GJ; Findlay JB; Kumar-Singh R; Kenna P; Humphries MM; Sharpe E; Humphries P
    Hum Mol Genet; 1992 Dec; 1(9):769-71. PubMed ID: 1302614
    [No Abstract]   [Full Text] [Related]  

  • 57. Necessary but insufficient.
    Papermaster DS
    Nat Med; 1995 Sep; 1(9):874-5. PubMed ID: 7585205
    [No Abstract]   [Full Text] [Related]  

  • 58. A Pro23His mutation alters prenatal rod photoreceptor morphology in a transgenic swine model of retinitis pigmentosa.
    Scott PA; Fernandez de Castro JP; Kaplan HJ; McCall MA
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2452-9. PubMed ID: 24618321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutation spectrum of the rhodopsin gene among patients with autosomal dominant retinitis pigmentosa.
    Dryja TP; Hahn LB; Cowley GS; McGee TL; Berson EL
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9370-4. PubMed ID: 1833777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Genotype-phenotype correlation in Chinese patients with retinitis pigmentosa due to rhodopsin mutation].
    Zhang Q; Zhang F; Xiao X; Li S; Shen H
    Yan Ke Xue Bao; 1999 Dec; 15(4):204-6, 235. PubMed ID: 12579668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.